Medicsen

Needle-free patch platform to deliver large drugs as insulin through painless and non-invasive ultrasound. Positive in vivo pig trials. Raising €5M (50% in)

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Leeds, United Kingdom
  • Currency EUR
  • Founded August 2015
  • Employees 16
  • Incorporation Type LLC
  • Website medicsen.com

Company Summary

We founded Medicsen after a young girl with diabetes refused to keep injecting 3 times per day while in the hospital consult of our CEO.

Our goal is to eliminate 30M injections from the world by 2028, increasing adherence to save 9,000 years of lifetime & 10% of the cost associated to complications.

We have a patented technology with strong evidence in vivo and a plan built with experts to obtain human evidence & secure commercial licenses.

Team

  • César de Mercado
    COO

    Telecom engineer, experience with signal processing and database management

  • Patricia Cremades
    CSO

    Bachelor in Medicine, resident in general surgery, experience with patient management, research and chronic diseases

  • José Carlos Montesinos Pérez
    CTO

    Telecom engineer, software architecture

  • Eduardo W. Jørgensen
    CEO

    Medical doctor, research experience, scientific and technological development experience

  • Diego peinado
    CFO

    Economics degree, masters in taxation, entrepreneurial spirit

  • Julia Imo
    Business development

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free